我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

失笑散治疗原发性痛经的网络药理学研究(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2020年03期
页码:
75-81
栏目:
方药研究
出版日期:
2020-11-15

文章信息/Info

Title:
Study on Network Pharmacology of Shixiao Powder in Treating Primary Dysmenorrhea
作者:
胡国静1隋新月1王潇1刘卉2△
1. 山东中医药大学第一临床医学院,山东 济南 250014;2. 山东中医药大学附属医院妇科,山东 济南 250014
Author(s):
HU Guojing1 SUI Xinyue1 WANG Xiao1 LIU Hui2
1. The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan 250014, China; 2. Department of Gynecology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China
关键词:
失笑散原发性痛经网络药理学
Keywords:
Shixiao Powder primary dysmenorrhea network pharmacology
分类号:
R285.5
DOI:
10.19288/j.cnki.issn.1000-2723.2020.03.014
文献标识码:
A
摘要:
目的 基于网络药理学对失笑散治疗原发性痛经的作用机制进行研究。方法 通过TCMSP、BATMAN-TCM数据库结合OB、DL、HL检索失笑散中蒲黄(Pollen Typhae)及五灵脂(Faeces Trogopterpri)的化学成分和作用靶点,并通过Uniprot数据库将靶点校正为基因名,运用Genecards数据库获取原发性痛经的相关靶点与基因。借助Cytoscape3.6.1软件构建化合物靶点相互作用图,利用VENNY图将原发性痛经的靶点和药物靶点进行分析,筛选出二者共同靶点,应用STRING数据库构建蛋白相互作用网络图(PPI),通过David数据库对关键靶点进行GO富集分析及KEGG通路富集分析。结果 筛选出失笑散治疗原发性痛经的12个有效成分,关键化合物为槲皮素和山奈酚;与治疗原发性痛经相关的靶点43个,关键靶点10个,主要靶点有IL-6、TNF、PTGS2、TP53、VEGFA等,10个关键靶点主要涉及细胞对缺氧的反应、肽基丝氨酸磷酸化的正向调节、炎症应答、NF-κB向核内输入的正调节等生物过程,通过参与肿瘤坏死因子信号通路、NOD样受体信号通路、NF-κB信号通路等参与治疗原发性痛经。结论 本研究从多角度探索了失笑散治疗原发性痛经的可能作用机制,揭示了失笑散通过多成分、多靶点、多途径治疗原发性痛经,为其临床应用及进一步研究奠定了理论基础。
Abstract:
Objective To explore the mechanism of Shixiao Powder in treating primary dysmenorrhea based on network pharmacology. Methods The TCMSP, BATMAN-TCM databases combined with OB, DL and HL were used to retrieve the chemical components and targets of Pollen Typhae and Faeces Trogopterpri in Shixiao Powder. The targets were corrected to gene name through Uniprot database, and the Genecards database was used to obtain the relevant targets and genes of primary dysmenorrhea. With the help of Cytoscape3.6.1 software, the compound target interaction diagram was constructed,the drug target and primary dysmenorrhea target were analyzed by using VENNY map, and the common target of the two are screened out. Using STRING database to construct protein Interaction Network Diagram(PPI). Gene Ontology(GO) enrichment analysis and KEGG pathway enrichment analysis were carried out on key targets through David database. Results 12 main components of Shixiao Powder in treating primary dysmenorrhea were screened out. The most important compounds are quercetin and kaempferol. 43 targets were related to primary dysmenorrhea, and 10 were key targets. The main targets are IL-6, TNF, PTGS2, TP53, VEGFA. The 10 key targets mainly involved in biological processes such as cell response to hypoxia, positive regulation of peptide serine phosphorylation, inflammatory response, positive regulation of NF-κB, etc. They participated in the treatment of primary dysmenorrhea through tumor necrosis factor signal pathway, NOD-like receptor signal pathway, NF-κB signaling pathway. Conclusion This study explored the possible mechanism of Shixiao Powder in the treatment of primary dysmenorrhea from multiple perspectives, revealing that Shixiao Powder acts through multi-component, multi-target and multi-pathway on primary dysmenorrhea. laying foundation for its clinicl and pharmacology study.

参考文献/References

[1] 寇小平,邵莹,卢占斌. 前列腺素F_(2α)受体与原发性痛经关系[J]. 现代仪器与医疗,2016,22(2):110-112.
[2] 杨继红,陈英,胡佳贞. 中学女生外周血前列腺素与原发性痛经关系[J]. 中国公共卫生,2011,27(8):1042-1043.
[3] 孙玉阳,纪宏宇,陈博,等. 原发性痛经的发病机制及中医药治疗的研究进展[J]. 中国药师,2017,20(1):144-147.
[4] PARK K S,PARK K I,HWANG D S,et al. A review of in vitro and in vivo studies on the efficacy of herbal medicines for primary dysmenorrhea[J]. Evid Based Complement Alternat Med,2014,2014:296860.
[5] 陈国佩,江海燕,李花春. 古方失笑散与中国药典方失笑散炮制的比较[J]. 广西中医药,1996(2):47-48.
[6] 解静,高杉,李琳,等. 网络药理学在中药领域中的研究进展与应用策略[J]. 中草药,2019,50(10):2257-2265.
[7] 于杰,张晓华. 失笑散加味对血瘀型原发性痛经患者子宫血流动力学的影响[J]. 福建中医药,2010,41(6):9-10.
[8] 史征. 妇科痛经丸治疗原发性痛经(寒凝血瘀证)的临床及实验研究[D]. 北京:北京中医药大学,2013.
[9] 杨爱萍,陈群,路艳. 原发性痛经疾病中医证候分布及相关因素的文献研究[J]. 时珍国医国药,2012,23(5):1258-1259.
[10] 吴燕芳. 失笑散古今应用[J]. 中成药研究,1987(4):32-33.
[11] 王海波,王章元. 中药蒲黄提取液的镇痛作用研究[J]. 医药导报,2006(4):278-279.
[12] 邱清华,邓绍云. 五灵脂化学成分与药用研究进展[J]. 江苏科技信息,2015(11):76-78.
[13] 庄婷婷,黄新华,叶翠河,等. 失笑散加味对血瘀型原发性痛经子宫血流动力学的影响[J]. 新中医,2015,47(7):199-200.
[14] 范萌. 少腹逐瘀汤治疗寒凝血瘀型原发性痛经临床观察[J]. 北京中医药,2011,30(6):455-456.
[15] LI Y,YAO J,HAN C,et al. Quercetin,inflammation and immunity[J]. Nutrients,2016,8(3):167.
[16] HOFER S,GEISLER S,LISANDRELLI R,et al. Pharmacological targets of kaempferol within inflammatory pathways-A hint towards the central role of tryptophan metabolism[J]. Antioxidants(Basel),2020,9(2):180.
[17] 钟华青. 桂枝茯苓胶囊治疗原发性痛经及对患者炎症因子的影响[J]. 临床医药文献电子杂志,2019,6(64):137.
[18] KANNAN P,CHEUNG K K,LAU B W. Does aerobic exercise induced-analgesia occur through hormone and inflammatory cytokine-mediated mechanisms in primary dysmenorrhea?[J]. Med Hypotheses,2019,123:50-54.
[19] 冯馨锐,崔雨舒,何志涛,等. 肿瘤坏死因子-α的生物学功能研究进展[J]. 吉林医药学院学报,2019,40(1):66-68.
[20] 禹龙香. 原发性痛经的发病机理与治疗[J]. 中国校医,2005(3):325-328.
[21] 周宇博,吴细兰,吴红斌. 壮医药线点灸对寒湿凝滞型痛经大鼠NF-κB及相关因子的影响[J]. 广西中医药,2018,41(5):59-61.
[22] 谢丹,居明乔,曹鹏,等. 炎症因子和原发性痛经相关性的研究进展[J]. 中国临床药理学与治疗学,2014,19(3):346-350.
[23] 席琼,胡巢凤. NOD样受体在炎症反应中的调控作用[J]. 生命科学,2010,22(5):454-458.
[24] DA SILVA CORREIA J,MIRANDA Y,AUSTIN-BROWN N, et al. Nod1-dependent control of tumor growth[J]. Proc Natl Acad Sci U S A., 2006,103(6):1840-1845.
[25] 林巧卫,张思,陆维祺. NOD样受体介导的信号转导通路及其与肿瘤关系的研究进展[J]. 中国癌症杂志,2019,29(3):223-228.

备注/Memo

备注/Memo:
收稿日期: 2020 - 04- 28 基金项目: 山东省中医药科技发展计划(2017-071) 第一作者简介: 胡国静(1995-),女,在读硕士研究生,研究方向:妇科常见病的中医药研究。 △通信作者: 刘卉,E-mail:13953108878@163.com
更新日期/Last Update: 2020-11-15